An open-label controlled trial of theophylline for treatment of patients with hyposmia

American Journal of the Medical Sciences

Volumn 337, Issue 6, 2009, Pages 396-406

  Henkin, Robert I ^a   Velicu, Irina ^a   Schmidt, Loren ^a  

^a Taste and Smell Clinic   (United States)

Author keywords

Cyclic nucleotides; Hyposmia; Phosphodiesterase inhibitors; Smell loss; Theophylline

Indexed keywords

NITROBENZENE; PENTYL ACETATE; PYRIDINE; THEOPHYLLINE; THIOPHENE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; FEMALE; FOLLOW UP; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; OLFACTORY DISCRIMINATION; OUTCOME ASSESSMENT; PERCEPTIVE THRESHOLD; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; MIDDLE AGED; PATHOPHYSIOLOGY; SMELLING DISORDER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OLFACTION DISORDERS; THEOPHYLLINE; TREATMENT OUTCOME;

EID: 67650273067     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181914a97     Document Type: Article

References (52)

1. Henkin RI. Evaluation and treatment of human olfactory dysfunction. In: English GM, editor. Otolaryngology, Vol.2. Philadelphia (PA): Lippincott; 1993. p. 1-86.
2. Henkin RI. Taste and smell disorders. In: Adelman G, Smith BH, editors. Human encyclopedia of neuroscience, 3rd ed. Boston (MA): Birkhauser; 2004.
3. Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 1991;177:519-528
4. Wysocki CJ, Gilbert AN. National Geographic Smell Survey: effects of age are heterogeneous. Ann NY Acad Sci 1989;561:12-28.
5. Temmel AFP, Quint C, Schickinger-Fischer B, et al. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002;128:635-641 (Pubitemid 34665843)
6. Cullen M, Leopold D. Disorders of smell and taste. Med Clin North Am 1999;83:57-74.
7. Bromley SM. Smell and taste disorders: a primary care approach. Am Fam Physician 2000;61:427-436 (Pubitemid 30067477)
8. Seiden AM, Duncan HJ, Smith DV. Office management of taste and smell disorders. Otolaryngol Clin North Am 1992;25:817-835
9. Davidson TM, Murphy C, Jalowayski AA. Smell impairment: can it be reversed? [Review] Postgrad Med 1995;98:107-9, 112-118
10. Harris R, Davidson TM, Murphy C, et al. Clinical evaluation and symptoms of chemosensory impairment: one thousand consecutive cases from the Nasal Dysfunction Clinic in San Diego. Am J Rhinol 2006;20:101-108
11. Henkin RI. Effects of ACTH, adrenocorticosteroids and thyroid hormone on sensory function. In: Stumpf WE, Grant LD, editors. Anatomical neuroendocrinology. Basel: Karger AG; 1975. p. 298-316.
12. Henkin RI. The role of adrenal corticosteroids in sensory processes, in adrenal gland. In: Blaschko H, Sayers G, Smith AD, editors. Handbook of physiology, endocrinology, Sect 7, Vol.VI. Washington, DC: Am Physiol Soc; 1975. p. 209-230
13. Henkin RI. Zinc, saliva and taste: interrelationships of gustin, nerve growth factor, saliva and zinc. In: Hambidge KM, Nichols BL, editors. Zinc and copper in clinical medicine. Jamaica (NY): Spectrum Publ Inc; 1978. p. 35-48.
14. Henkin RI, Lippoldt RE, Bilstad J, et al. A zinc protein isolated from human parotid saliva. Proc Natl Acad Sci USA 1975;72:488-492
15. Henkin RI, Lippoldt RE, Bilstad J, et al. Fractionation of human parotid saliva. J Biol Chem 1978;253:7556-7565
16. Henkin RI, Doherty AE, Martin BM. Nasal seroproteins: a new frontier in the exploration of physiology and pathology of nasal and sinus disease. In: Veldman JE, Passali D, Lim DJ, editors. New frontiers in immunobiology in otolaryngology. The Hague (Netherlands): Kugler; 2000. p. 127-152
17. Henkin RI, Martin BM, Agarwal RP. Decreased parotid saliva gustin/carbonic anhydrase VI secretion: an enzyme disorder manifested by gustatory and olfactory dysfunction. Am J Med Sci 1999;318:380-391
18. Doerty AE, Matin BM, Dai WL, et al. Carbonic anhydrase (CA) activity in nasal mucus appears to be a marker for loss of smell (hyposmia) in humans. J Invest Med 1997;45:237A.
19. Henkin RI, Martin BM, Agarwal RP. Efficacy of exogenous zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci 1999;318:392-404.
20. Henkin RI, Velicu I. Age related changes in cyclic nucleotides in saliva and nasal mucus-possible feedback mechanism in development of gustatory and olfactory receptor function. FASEB J 2005;19:A1368.
21. Papathanassiu A, Henkin RI. cAMP is present in human nasal mucus and may act as a growth factor in cells of the olfactory epithelium. FASEB J 2002;16:A1153.
22. Asakura K, Kataura A. cAMP and cGMP in the human parotid saliva. Arch Otorhinolaryngol 1980;226:1529-1530
23. Schaeffer LD, Sproles A, Krakowski A. Detection of cAMP in parotid saliva of normal individuals. J Dent Res 1973;52:629.
24. Glenert U, Geisler A. A single assay for cyclic adenosine 3′:5′-monophosphate in human saliva. J Cyclic Nucleotide Protein Phosphor Res 1985;10:451-461 (Pubitemid 16195077)
25. Hanamori T, Nagotsu T, Matsumoto S. Origin of cyclic adenosine monophosphate in saliva. J Dent Res 1975;54:535-539
26. Rosenzweig S, Yan W, Sasso M, et al. Possible novel mechanism for bitter taste mediated through cGMP. J Neurophysiol 1999;81:1661-1665 (Pubitemid 29262498)
27. Pace U, Hanski E, Salomon Y, et al. Odorant-sensitive adenylate cyclase may mediate olfactory reception. Nature 1985;316:255-258 (Pubitemid 15073690)
28. Anholt RR. Molecular neurobiology of olfaction. Crit Rev Neurobiol 1993;7:1-22.
29. Firestein S, Zufall F, Sheperd GM. Single odor-sensitive channels in olfactory receptor neurons are also gated by cyclic nucleotides. J Neurosci 1991;11:3565-3572
30. Moon C, Simpson PJ, Cho H, et al. Regulation of intracellular cyclic GMP levels in olfactory sensory neurons. J Neurochem 2005;95:200-209 (Pubitemid 41384438)
31. Henkin RI, Velicu I, Papathanasiu A. cAMP and cGMP in human parotid saliva: relationships to taste and smell dysfunction, gender and age. Am J Med Sci 2007;334:431-440 (Pubitemid 350306462)
32. Henkin RI, Velicu I. cAMP and cGMP in nasal mucus: relationships to taste and smell dysfunction, gender and age. Clinical Invest Med 2008;31:E71-E77.
33. Henkin RI. The definition of primary and accessory areas of olfaction as the basis for a classification of decreased olfactory acuity. In: Hayashi T, editor. Olfaction and taste II. London: Pergamon Press; 1967. p. 235-252
34. Henkin RI, Velicu I. cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction. Clinical Invest Med 2008;31:E78-E84.
35. Cai D, Qiu J, Cao Z, et al. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci 2001;21:4731-4739 (Pubitemid 32565631)
36. Neumann S, Bradke F, Tessier-Lavigne M, et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 2002;34:885-893 (Pubitemid 34722279)
37. Cai D, Shen Y, DeBellard M, et al. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP dependent mechanism. Neuron 1999;22:89-101. (Pubitemid 29070096)
38. Kurihara K, Koyama N. High activity of adenylyl cyclase in olfactory and gustatory organs. Biochem Biophys Rev Comm 1972;48:30-34
39. Moon C, Simpson PJ, Cho H, et al. Regulation of intracellular cyclic GMP levels in olfactory sensory neurons. J Neurochem 2005;95:205-209 (Pubitemid 41384438)
40. Shepherd GM. Sensory transduction entering the mainstream of membrane signaling. Cell 1991;67:845-851
41. Thompson WJ. Cyclic nucleotide phosphodiesterase: pharmacology, biochemistry and function. Pharmacol Ther 1991;51:13-33.
42. Firestein BI, Bredt DS. Regulation of sensory neuron precursor proliferation by cyclic GMP-dependent protein kinase. J Neurochem 1998;71:1846-1853
43. Henkin RI, Velicu I, Papathanasiu A. Dichotomous changes in cAMP and cGMP in human parotid saliva after oral theophylline. FASEB J 2003;17:A1028.
44. Velicu I, Henkin RI. On the antiapoptotic mechanism of action of theophylline in restoring smell function in patients with hyposmia. J Invest Med 2005;53(Suppl. 2):S402.
45. Levy LM, Henkin RI, Hutter A, et al. Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI. J Comp Asst Tomog 1998;22:760-770 (Pubitemid 28457740)
46. Henkin RI, Velicu I, Schmidt L. Effective treatment of smell loss with theophylline. Exp Biol 2008;22:B976.2.
47. Henkin RI, Larson AL, Powell RD. Hypogeusia, dysgeusia, hyposmia and dysosmia following influenza-like infection. Ann Otol Rhin Laryngol 1975;84:672-682
48. Church JA, Bauer H, Bellanti JA, et al. Hyposmia associated with atopy. Ann Allergy 1978;40:105-109
49. Schechter PJ, Henkin RI. Abnormalities of taste and smell following head trauma. J Neurol Neurosurg Psychiat 1974;37:802-810
50. Henkin RI, Schecter PJ, Friedewald WT, et al. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 1976;272:285-299
51. Henkin RI, Schechter PJ, Hoye RC, et al. Idiopathic hypogeusia with dysgeusia, hyposmia and dysosmia: a new syndrome. J Am Med Assoc 1971;217:434-440
52. Schechter PJ, Friedwald WT, Bronzert DA, et al. Idiopathic hypogeusia: a description of the syndrome and a single blind study with zinc sulfate. In: Pfeiffer C, editor. Int Rev Neurobiol Suppl 1, New York (NY): Academic Press; 1972. p. 125-133